5 research outputs found

    Diagnosis and treatment of coincident Hodgkin's lymphoma and hamartoma by endobronchial methods: A Case report

    No full text
    Endobronchial ultrasound-transbronchial needle aspiration (EBUS-TBNA) is recommended for the diagnosis of malign and benign mediastinal lymphadenopathies and lesions adjacent to the central airways. However the diagnostic yield of EBUS-TBNA in diagnosis of lymphoma is weak. Additionally, the challenge of cathcing Reed-Sternberg cells in such a small sample size lowers the sensitivitiy of EBUS-TBNA for diagnosis of Hodgkin lymphoma. EBUS-TBNA can be performed with rigid bronchoscopy. A 64 years old male patient with multiple abdominal and mediastinal lymphadenopathies with coinciding hamartoma and Hodgkin lymphoma is reported for presenting diagnostic and therapeutic interventional methods performed for this unique coincidance

    Can we predict patients that will not benefit from invasive mechanical ventilation? A novel scoring system in intensive care: the IMV mortality prediction score (IMPRES)

    No full text
    KUCUK, Ahmet Oguzhan/0000-0002-6993-0519; Kirakli, Cenk/0000-0001-6013-7330; KUCUK, Mehtap PEHLIVANLAR/0000-0003-2247-4074; Aksoy, Iskender/0000-0002-4426-3342WOS: 000504051300010PubMed: 31655511Background/aim: The present study aimed to define the clinical and laboratory criteria for predicting patients that will not benefit from invasive mechanical ventilation (IMV) treatment and determine the prediction of mortality and prognosis of these critical ill patients. Materials and methods: The study was designed as an observational, multicenter, prospective, and cross-sectional clinical study. It was conducted by 75 researchers at 41 centers in intensive care units (ICUs) located in various geographical areas of Turkey. It included a total of 1463 ICU patients who were receiving invasive mechanical ventilation (IMV) treatment. A total of 158 parameters were examined via logistic regression analysis to identify independent risk factors for mortality; using these data, the IMV Mortality Prediction Score (IMPRES) scoring system was developed. Results: The following cut-off scores were used to indicate mortality risk: 8, very high risk. There was a 26.8% mortality rate among the 254 patients who had a total IMPRES score of lower than 2. The mortality rate was 93.3% for patients with total 1M PRES scores of greater than 8 (P < 0.001). Conclusion: The present study included a large number of patients from various geographical areas of the country who were admitted to various types of ICUs, had diverse diagnoses and comorbidities, were intubated with various indications in either urgent or elective settings, and were followed by physicians from various specialties. Therefore, our data are more general and can be applied to a broader population. This study devised a new scoring system for decision-making for critically ill patients as to whether they need to be intubated or not and presents a rapid and accurate prediction of mortality and prognosis prior to ICU admission using simple clinical data
    corecore